Please login to the form below

Not currently logged in
Email:
Password:

Takeda promotes Trevor Smith to CEO

Takeda Pharmaceuticals has appointed Trevor Smith as chief executive for Europe following the departure of Dr Erich Brunn

Trevor Smith has been appointed chief executive of Takeda Pharmaceuticals Europe following the departure of Dr Erich Brunn.

Smith brings more than 30 years of pharmaceutical experience and a broad range of knowledge to the leadership role in Europe.

He has worked at Takeda for more than 10 years and served in various roles, including managing director of Takeda UK and vice president, new portfolio for Takeda Pharmaceuticals Europe.

Before joining Takeda, Smith served at Servier Laboratories as managing director of Servier South Africa and held the role in the UK. He also worked as the vice president of Northern Europe, based at the company's parent organisation in Paris, France.

Frank Morich, the company's head of international operations (Americas/Europe), said: "With Trevor's leadership and guidance, our European businesses will align their commercial strategies to ensure Takeda's continued growth and evolution in the region."

Smith replaces Dr Erich Brunn, who leaves Takeda. Brunn joined the company in 2001 as president of Takeda's operations in Germany.

21st April 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics